drugset / Trial / NCT01699607
Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion Paradigm
Completed
10 enrolled
Yale University
National Cancer Institute (NCI) · collabNational Institute of Mental Health (NIMH) · collab
NaSingle-groupOpen-labelOther
Summary
A research study designed to examine amphetamine-induced dopamine release using the PET imaging agent \[11C\]PHNO in tobacco smokers while currently smoking and during acute withdrawal and in nonsmokers. Twenty healthy men and women tobacco smokers and twenty healthy nonsmokers will be recruited. Each subject will participate in 1 MRI and up to 2 \[11C\]PHNO PET scans. On the study day subjects will participate in two \[11C\]PHNO scans (ideally, the two PET scans will be carried out in the same day). Three hours before the second PET scan, amphetamine (0.5 mg/kg, PO) will be administered. In smokers, the scan will occur at 10-21 days of smoking abstinence.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amphetamine | Unknown | 0.5 mg/kg | Oral |